Richard B. Slansky

This profile gathers the share dealings of Richard B. Slansky across 4 companies, led by Digirad Corp, ONCOSEC MEDICAL Inc and GenMark Diagnostics, Inc. In total, 46 filings cover trades dated from 1 May 2006 to 5 July 2018.

Both buying and selling appear: 2 purchases worth €915k, against 15 sales worth €145k. On balance, insiders were net buyers of €769k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 16 share grants and 13 option exercises. Since January 2018: no purchases and 11 sales on the market.

On 6 July 2018 came the latest disclosure, an option exercise in ONCOSEC MEDICAL Inc. The clock since the last published purchase (8 July 2015) now reads 4,141 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.